Bortezomib suppresses renal tubular epithelial-mesenchymal transition induced by TNF-α through downregulation of Smurf2 in HK-2 cells
- Author:
- No author available
- Journal Title:
- Chinese Journal of Organ Transplantation
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.0254-1785.2018.04.009
- Key Word:
- 肾移植;硼替佐米;肾间质纤维化;肾小管上皮细胞;Kidney transplantation;Bortezomib;Renal tubular interstitial fibrosis;Renal tubular epithelial cells
Abstract： Objective To investigate the effect of Bortezomib on renal tubular epithelialmesenchymal transition (EMT),and to determine whether Smad ubiquitin regulatory factor 2 (Smurf2) expression induced by tumor necrosis factor-α (TNF-α) can be reversed by Bortezomib in human renal tubular epithelial cells (HK-2).Methods The HK-2 cells were divided into control group (cultured with fetal bovine serum),TNF-α group (cultured with TNF-α),Bortezomib group (cultured with Bortezomib) and experimental group (treated with Bortezomib and TNF-α together).Each group of cells was observed under an inverted microscope,and then the cells of each group were collected.RT-PCR and Western blotting were performed to detect the expression levels of fibronectin (FN),Smurf2,E-cadherin and α-smooth muscle actin (α-SMA).Results As compared with the TNF-α-treated group,the morphology of HK-2 cells was still cobblestone-like after intervention with bortezomib;however,the cellular morphology did not change significantly in the bortezomib-treated group as compared with the control group.As compared with the control group,the expression of FN mRNA and protein in the TNF-α group was significantly increased (P＜0.05).As compared with the TNF-α group,bortezomib inhibited the expression of FN induced by TNF-α (P＜0.05) There was no significant difference in the expression of FN between bortezomib-treated group and control group (P ＞0.05).As compared with the control group,E cadherin was significantly decreased in HK-2 cellsafter treatment with TNF-α,and α-SMA was significantly increased (P＜0.05).As compared with TNFα group,co-stimulation with bortezomib reversed the expression of E cadherin and α-SMA induced by TNF-α (P ＜ 0.05),but the expression of E-cadherin and α-SMA did not change significantly in the bortezomib-treated group as compared with the control group (P ＞ 0.05).As compared with the control group,TNF-α could increase the expression of Smurf2 mRNA and protein (P＜0.05),and bortezomib could inhibit the increase in Smurf2 induced by TNFα (P＜0.05).As compared with the control group,the expression of Smurf2 did not change significantly in the bortezomib-treated group (P＞0.05).Conclusion Bortezomib can antagonize the expression of Smurf2 and EMT induced by TNF-α in HK-2 cells.
- [1]赵春春,索传健,顾民,等.肿瘤坏死因子-α在慢性移植肾间质纤维化形成中的作用机制研究[J].2016,(11).
- [2]张志,况芳,刘昌玲,等.沉默Smad泛素化调节因子2基因对人增生性瘢痕成纤维细胞功能的影响[J].2017,(3).
- [3]Pardo,A.,Rivera,S.,Wu,M.,etc.Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β 1 signalling[J].2012,67(2).
- [4]Fineschi, Serena,Reith, Walter,Guerne, Pierre André,etc.Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and upregulating metalloproteinase-1 production in human dermal fibroblasts.[J].2006,20(3).
- [5]Koichiro, Tashiro,Satoshi, Tamada,Nobuyuki, Kuwabara,etc.Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB.[J].2003,12(4).
- [6]Zhao, Chunchun,Xu, Zhen,Wang, Zijie,etc.Role of tumor necrosis factor-alpha in epithelial-to-mesenchymal transition in transplanted kidney cells in recipients with chronic allograft dysfunction[J].2018,642.
- [7]Finnerty,C.C.,He,J.,Herndon,D.N.,etc.Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children[J].2012,38(2).
- [8]Li, Xiuji,Liu, Ruixia,Wang, Liyan,etc.The downregulation of SnoN expression in human renal proximal tubule epithelial cells under high-glucose conditions is mediated by an increase in Smurf2 expression through TGF-beta 1 signaling[J].2016,37(2).
- [9]Laule M,Mrozikiewicz A,Meiners S,etc.Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome.[J].2004,44(4).
- [10]Mohammad Reza, Ganji,Abdolreza, Harririan.Chronic allograft dysfunction: major contributing factors.[J].2012,6(2).
- [11]Bruce, Kaplan.Overcoming barriers to long-term graft survival.[J].2006,47.
- [12]Wafaa, Fadili,Mustapha, Habib Allah,Inass, Laouad.Chronic renal allograft dysfunction: risk factors, immunology and prevention.[J].2013,6(1).
- [13]Wang, Wenjie,Luo, Judong,Sheng, Wenjiong,etc.Proteomic Profiling of Radiation-Induced Skin Fibrosis in Rats: Targeting the Ubiquitin-Proteasome System[J].2016,95(2).
- [14]Al-Lamki, Rafia S.,Mayadas, Tanya N..TNF receptors: signaling pathways and contribution to renal dysfunction[J].2015,87(2).
- [15]Herwig-Ulf Meier-Kriesche,Jesse D. Schold,Bruce Kaplan.Long-Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?[J].2004,4(8).
- [16]Sepideh, Zununi Vahed,Naser, Samadi,Mohammadreza, Ardalan.Diagnosis of interstitial fibrosis and tubular atrophy in kidney allograft: implementation of microRNAs.[J].2014,8(1).